Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: BioMerieux Appoints New Directors; Exosome Hires Kelly as CFO

Premium

BioMérieux this week appointed of two new independent directors, Agnès Lemarchand and Philippe Gillet. Lemarchand and Gillet are replacing Georges Hibon and Michel Angé, who did not wish to renew their terms on the company's board.

Lemarchand has served as CEO of Industrie Biologique Française, a joint venture between the Rhône-Poulenc group and Institut Mérieux. She has also served as chairman and CEO of Prodical, a subsidiary of the Ciments Français group; and chairman and CEO of the Lafarge group's lime business.

Gillet was a professor of geophysics at the University of Rennes prior to becoming director of l’Ecole Normale Supérieure de Lyon, where he was also a professor of earth sciences. In addition, from May 2007 to April 2010 he served as chief of staff for the French Minister of Higher Education and Research. He subsequently joined l’Ecole Polytechnique Fédérale of Lausanne, where he serves as vice president for academic affairs.


Exosome Diagnostics has named William Kelly as CFO.

Kelly has worked for RepliGen for the past six years, serving as the principal financial officer there for more than five years. He has also served as corporate controller of Haemonetics, and has worked for Deloitte & Touche.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.